Matthew Autterson – CEO and President of CNS BioScience

Matthew Autterson was born and brought up in Detroit, in the U.S. state of Michigan. He graduated from Brother Rice High School in 1975 and then went to study at Michigan State University, where he managed to successfully complete his academic Bachelor’s degree in Finances in 1975. From there, Matthew Autterson went on to the Denver Graduate Tax Program for his further studies. Currently, Mr. Matthew Autterrson serves at Falci Adaptive Biosystems as a member of the Board of Directors. Moreover, Matthew Autterrson is a charitable person. His philanthropic acts have led him to chair positions on the Board of the Denver Zoological Foundation. Also, he has held a position on Board of Directors of Denver Hospice as the chairman.

Matthew Autterson started his profession when he served for a branch Fiserv named First Trust Corporation. In 1982, he left the organization and teamed up with a small group to establish a new Colorado State chartered trust firm, a subsidiary of Integrated Resources, Inc. Integrated Resources, Inc is a financial services organization based in New York. Matthew later became the president of Colorado State chartered trust company in 1986. Broad, Inc. later acquired the company and its assets in 1989. Broad, Inc. later turned into SunAmerica, Inc. 1n 1998, SunAmerica, Inc was acquired for over $18 billion by AIG. AIG presently serves over 200,000 customers providing them with custodial and depository services.

Falci Adaptive Biosystems, as a lead in Colorado’s Business Community, represents Matthew Autterson’s endeavors in assisting with many years of positions in leadership to aid in taking part with the Board of the Denver Zoo. Autterson also demonstrated his charitable acts by participating as a member of World Presidents Organization and Young Presidents Organization.

Currently, Matthew Autterson has managed to earn a big name, serving at CNS BioScience’s on Board of Directors. He is also the acting Chief Executive Officer and President of CNS BioScience. The company was established by Scott Falci, M.D. in 2013. CNS BioScience is a drug development firm, still at a clinical stage, focusing largely on offering treatment services to patients suffering from neuropathic pain.

Matthew Autterson is a recognized figure due to his passionate activities of giving help to the business world and community. Mr. Autterson has used his expertise in estate planning and investment strategy to aid others to improve their business goals. Mr. Autterson has also advised many people when it comes to matters concerning managing their finance.